← Mechanisms of action
WT1
SINGLE PROTEINHomo sapiens
Preferred name: Wilms tumor protein ChEMBL ↗
Linked proteins
Drugs acting on this target (13)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cue-102 | Binding agent | experimental | Recombinant protein | binding agent - wt1 |
| rg 6007 | Binding agent | experimental | mAb | WT1 binding agent |
| dsp-7888 | Immunity, active | experimental | Vaccine | immunity, active - wt1 |
| galinpepimut-s | Immunity, active | experimental | Vaccine | immunity, active - wt1 |
| gsk2130579a | Immunity, active | experimental | Vaccine | WT1 immunity, active |
| il15-transpresenting wt1-targeted dendritic cell vaccine | Immunity, active | experimental | Vaccine | immunity, active - WT1 |
| ocv-501 | Immunity, active | experimental | Vaccine | immunity, active - wt1 |
| p.dom-wt1-37 dna vaccine and p.dom-wt1-126 dna vaccine | Immunity, active | experimental | Biological | immunity, active - wt1 |
| donor-derived wt1-ctl and p-ctl | Immunity, passive | experimental | Cell therapy | immunity, passive - wt1 |
| ntla-5001 | Immunity, passive | experimental | Cell therapy | immunity, passive - wt1 |
| wt1 tcr-transduced t cells | Immunity, passive | experimental | Cell therapy | immunity, passive - wt1 |
| wt1-sensitized allogeneic t-lymphocytes | Immunity, passive | experimental | Cell therapy | immunity, passive - wt1 |
| galinpepimut-s | Vaccine antigen | experimental | Vaccine | Wilms tumor protein vaccine antigen |